Antiphospholipids in periodontitis
抗磷脂在牙周炎中的作用
基本信息
- 批准号:9232123
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2021-02-28
- 项目状态:已结题
- 来源:
- 关键词:AffectAnnexinsAntibodiesAntibody ResponseAnticardiolipin AntibodiesAntigen TargetingAntigensAntiphospholipid SyndromeAtherosclerosisAutoimmune DiseasesBindingBinding SitesBiologicalC5a anaphylatoxin receptorCardiovascular DiseasesCell Adhesion MoleculesCell LineCellsChoriocarcinomaChronicClinicalClinical ResearchComplementComplement 5aComplement ActivationDataDeciduaDependenceDepositionDevelopmentDiabetes MellitusDiagnostic testsEndothelial CellsExcisionFailureFetal DevelopmentFetal Growth RetardationFibrinFirst Pregnancy TrimesterFoundationsFunctional disorderFutureGlycoproteinsHealthHumanHuman Chorionic GonadotropinImmunizationImmunoglobulin GImmunoglobulin MIn VitroInfectionInflammationInflammatoryInflammatory ResponseInjuryInterventionLinkLow Birth Weight InfantModelingMolecular MimicryMouse StrainsMusOralOutcomePathologicPatientsPeriodontal DiseasesPeriodontal InfectionPeriodontitisPersonsPhosphatidylserinesPlacentationPorphyromonas gingivalisPre-EclampsiaPregnancyPregnancy OutcomePregnancy lossPreparationPreventionProductionReceptor CellRiskRoleSamplingSequence HomologsSerumSerum ProteinsSiteSolidSourceSystemic Lupus ErythematosusSystemic diseaseTLR2 geneTLR4 geneTLR8 geneThrombosisThrombusTrophoblastic CellVascular Endothelial CellWomanadverse outcomeadverse pregnancy outcomeannexin A5beta 2-glycoprotein Icell motilitycell typecross reactivitycrosslinkcytokineexperimental studyfetalimmunoreactivityin vivoinhibitor/antagonistmicroorganismmigrationmonolayermouse modelpathogenpatient populationpregnantprematureprotein aminoacid sequencepublic health relevancereceptorresponsetrophoblastvascular inflammation
项目摘要
DESCRIPTION (provided by applicant): Anticardiolipin antibodies (aCL), which are commonly present in autoimmune diseases such as systemic lupus erythematosus and the antiphospholipid syndrome (APS), are also present in 15-20% of serum samples from patients with chronic or generalized aggressive periodontitis. In APS, these antibodies are associated with thrombus formation, fetal loss and fetal growth restriction, preeclampsia, and atherosclerosis. In periodontitis, it is likely that these antibodies are produced in response to oal bacterial pathogens such as Porphyromonas gingivalis and others, which have peptide sequences that are homologous to a key sequence on beta-2 glycoprotein-I (2GPI) the target antigen of aCL. aCL is thought to affect pregnancy in women with APS due to a variety of biological mechanisms with effects on placentation (impacting the decidua and trophoblast), thrombosis, and systemic and local inflammation. Our data indicate that aCL levels in periodontitis are associated with elevated markers of vascular inflammation, and that periodontal treatment decreases IgM aCL antibody levels (but not IgG levels), implicating the oral microflora as a source of antigen. aCL antibodies from periodontitis patients also induce inflammatory responses in cultured vascular endothelial cells (HUVEC). In addition, these antibodies promote competition of 2GPI with Annexin V for binding sites on phosphatidylserine. Annexin V binding to PS on trophoblasts is thought to be an important protective mechanism during fetal development, so the data indicate that such antibodies could cause trophoblast inflammatory responses and fibrin deposition leading to inflammation and defective cell migration. We further found that antibody raised against P. gingivalis contains aCL which causes fetal loss in a mouse pregnancy model. We therefore hypothesize that cross-reactive anticardiolipin antibodies induced by P. gingivalis promote inflammatory responses in endothelial cells and trophoblasts that are consistent with their ability to cause complement-dependent fetal loss in mice. We propose to further study the mechanisms by which aCL in anti- P. gingivalis interacts with receptors such as TLR2, TLR4, and TLR8, and with Annexin A2 on HUVEC to induce inflammatory cytokine production. We further propose to examine the interactions of aCL induced by P. gingivalis with trophoblastic cell lines. These studies will examine disruption of the Annexin V protective shield and examine effects on complement activation, cytokine production, human chorionic gonadotropin production, and cell migration. We will also examine the dependence of fetal loss due to anti- P. gingivalis on complement activation and on C5a-C5a receptor interaction in the mouse pregnancy model. We will integrate studies examining human aCL derived from periodontitis patients, evaluating their in vitro and in vivo effects in parallel experiments. Results of these studies, if consistent with our hypothesis, would implicate molecular mimicry of 2GPI by P. gingivalis as a likely mechanism linking periodontitis with adverse pregnancy outcomes in both the mouse pregnancy model and in human pregnancy.
描述(由申请人提供):抗心磷脂抗体 (aCL) 常见于自身免疫性疾病,如系统性红斑狼疮和抗磷脂综合征 (APS),也存在于 15-20% 的慢性或全身性疾病患者的血清样本中在 APS 中,这些抗体与血栓形成、胎儿流产和胎儿生长受限、先兆子痫和动脉粥样硬化有关。牙周炎中,这些抗体很可能是针对口腔细菌病原体(例如牙龈卟啉单胞菌等)而产生的,这些病原体的肽序列与 aCL 靶抗原 β-2 糖蛋白-I (2GPI) 上的关键序列同源由于多种生物学机制影响胎盘(影响蜕膜和滋养层)、血栓形成和妊娠,aCL 被认为会影响 APS 女性的妊娠。我们的数据表明,牙周炎中的 aCL 水平与血管炎症标志物升高有关,并且牙周治疗会降低 IgM aCL 抗体水平(但不会降低 IgG 水平),这表明口腔微生物群是 aCL 抗体的来源。来自牙周炎患者的抗体还会诱导培养的血管内皮细胞 (HUVEC) 的炎症反应。此外,这些抗体还促进 2GPI 与膜联蛋白 V 竞争结合位点。磷脂酰丝氨酸与滋养细胞上的 PS 结合被认为是胎儿发育过程中的重要保护机制,因此数据表明此类抗体可能引起滋养层炎症反应和纤维蛋白沉积,从而导致炎症和细胞迁移缺陷。抗牙龈卟啉单胞菌含有aCL,可导致小鼠妊娠模型中胎儿流产,因此我们认为牙龈卟啉单胞菌诱导的交叉反应性抗心磷脂抗体会促进小鼠的炎症反应。我们建议进一步研究抗牙龈卟啉单胞菌中的aCL与TLR2、TLR4和TLR8等受体相互作用的机制。 HUVEC 上的膜联蛋白 A2 诱导炎症细胞因子的产生,我们进一步建议检查牙龈卟啉单胞菌诱导的 aCL 与滋养层细胞系的相互作用。我们还将研究抗牙龈卟啉单胞菌引起的胎儿丢失对补体激活和 C5a-C5a 受体相互作用的依赖性。我们将整合来自牙周炎患者的人类 aCL 的研究,在平行实验中评估其体外和体内效果,如果这些研究结果与我们的假设一致,则意味着分子模拟。牙龈卟啉单胞菌的2GPI可能是小鼠妊娠模型和人类妊娠中牙周炎与不良妊娠结局相关的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HARVEY Allen SCHENKEIN其他文献
HARVEY Allen SCHENKEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HARVEY Allen SCHENKEIN', 18)}}的其他基金
Antiphospholipids and vascular inflammation in aggressive periodontitis
侵袭性牙周炎中的抗磷脂和血管炎症
- 批准号:
8033111 - 财政年份:2008
- 资助金额:
$ 38.13万 - 项目类别:
Antiphospholipids and vascular inflammation in aggressive periodontitis
侵袭性牙周炎中的抗磷脂和血管炎症
- 批准号:
7568848 - 财政年份:2008
- 资助金额:
$ 38.13万 - 项目类别:
Antiphospholipids and vascular inflammation in aggressive periodontitis
侵袭性牙周炎中的抗磷脂和血管炎症
- 批准号:
7767678 - 财政年份:2008
- 资助金额:
$ 38.13万 - 项目类别:
Antiphospholipids and vascular inflammation in aggressive periodontitis
侵袭性牙周炎中的抗磷脂和血管炎症
- 批准号:
7370942 - 财政年份:2008
- 资助金额:
$ 38.13万 - 项目类别:
Periodontitis, Anti-phospholipids, Dendritic Cells, and Atherosclerosis
牙周炎、抗磷脂、树突状细胞和动脉粥样硬化
- 批准号:
7595038 - 财政年份:2007
- 资助金额:
$ 38.13万 - 项目类别:
GENETIC AND IMMUNOLOGIC ASPECTS OF PERIODONTAL DISEASES
牙周疾病的遗传和免疫学方面
- 批准号:
6651157 - 财政年份:2000
- 资助金额:
$ 38.13万 - 项目类别:
GENETIC AND IMMUNOLOGIC ASPECTS OF PERIODONTAL DISEASES
牙周疾病的遗传和免疫学方面
- 批准号:
6142033 - 财政年份:2000
- 资助金额:
$ 38.13万 - 项目类别:
相似国自然基金
基于膜联蛋白A与钙离子协同作用探讨复方生地颗粒免疫抑制效应的成分靶向研究
- 批准号:82374109
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
膜联蛋白A1通过调节线粒体稳态改善糖尿病肾病肾损伤的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
膜联蛋白A4低氧环境下调控滋养层细胞功能及新生血管形成在复发性流产中的作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
膜联蛋白A1调控脂代谢重编程促进急性B淋巴细胞白血病化疗耐药的机制研究
- 批准号:82160704
- 批准年份:2021
- 资助金额:33 万元
- 项目类别:地区科学基金项目
猪囊尾蚴膜联蛋白介导免疫抑制的分子机制研究
- 批准号:32160842
- 批准年份:2021
- 资助金额:35 万元
- 项目类别:地区科学基金项目
相似海外基金
Simultaneous Imaging of Tumor and Host Cells in the Microenvironment
微环境中肿瘤和宿主细胞的同步成像
- 批准号:
10387354 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Simultaneous Imaging of Tumor and Host Cells in the Microenvironment
微环境中肿瘤和宿主细胞的同步成像
- 批准号:
10549299 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Nephritogenic autoantibodies in systemic lupus
系统性狼疮中的肾炎性自身抗体
- 批准号:
9034312 - 财政年份:2016
- 资助金额:
$ 38.13万 - 项目类别:
Improved survival in sepsis with LFA-1blockade evaluation of lymphocyte activatio
LFA-1 阻断评估淋巴细胞活化可提高脓毒症患者的生存率
- 批准号:
8679938 - 财政年份:2014
- 资助金额:
$ 38.13万 - 项目类别:
Improved survival in sepsis with LFA-1blockade evaluation of lymphocyte activatio
LFA-1 阻断评估淋巴细胞活化可提高脓毒症患者的生存率
- 批准号:
8884623 - 财政年份:2014
- 资助金额:
$ 38.13万 - 项目类别: